ArticleAmerican journal of preventive medicine2025
State Nonmedical Cannabis Laws and U.S. Young Adults' Cannabis-Related Experiences.
Article in American journal of preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cannabis retailers' marketing practices and compliance with state regulations: a 2025 point-of-sale audit in 5 U.S. cities.Addictive behaviors · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionThis study investigated the associations between cannabis retail laws and relevant experiences (e.g., advertising exposure) among young adults, who have the highest use prevalence.
methodsThree categories of nonmedical cannabis retail-related laws were examined: (1) operational restrictions (e.g., operating hours, zoning restrictions), (2) advertising restrictions (by media channels, health claims, giveaways/discounts), and (3) required warnings (in ads, at retailers). Dependent variables were from surveys of U.S. young adults in 19 states with nonmedical cannabis retail (June-November 2023), including frequency of cannabis retailer visits, advertising exposure; driving after use; and (for those with past-year retailer visits and past-month use) noticing minimum-age signage, health claims, giveaways, and discounts at retailers. Multivariable analyses examined retail-related laws in relation to relevant outcomes.
resultsAmong all participants (N=1,847), associations were found between retail license limits and fewer retailer visits, restricting billboard ads and less billboard ad exposure, and requiring driving-related warnings in ads and less likely driving after use. Among those who visited retailers (n=843), there were associations between zoning restrictions for youth-oriented facilities (but not schools) and noticing minimum-age signage, restricting health claims on products and lower health claim exposure, restricting giveaways and less often noticing giveaways, and restricting discounts and more often noticing discounts. There were no other significant associations (e.g., restricting online advertising and exposure, required warnings with risk perceptions).
conclusionsCertain laws were associated with anticipated experiences among young adults; however, other laws showed no association with outcomes. Ongoing research assessing population impact and industry compliance is needed to inform regulations and implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.